PETALING JAYA: UEM Edgenta Bhd’s proactive approach to navigating through the Covid-19 pandemic and its 2025 roadmap is seen as a positive step ahead by analysts.
RHB Research has upgraded the stock from “neutral” to “buy” with a fair value of RM2.05 a share.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!